{"summary": "SERMs selectively inhibit the entry of the Ebola pseudovirion, but not through the estrogen receptor pathway. all stages of Ebola entry are mediated by trimeric GP spikes arrayd around the Ebola particles29,30. the pseudovirion model with Ebola GP can simulate the stages of wild-type Ebola entry. cells were pretreated with 10 nM E2, 100 nM ICI, 10 M tamoxifen, and 10 M clomiphene for 1 h. the cells were then lysed, and the luciferase assay was carried out. NH4Cl serves as a negative control. CADs with selective anti-Ebola activity may target NPC1 to inhibit Ebola entry. in all cases, we did not detect interactions by MST or ITC. compared the effective SERMs dosages for cholesterol accumulation and Ebola entry inhibition. intriguingly, the cholesterol accumulation appeared after 8 h of SERMs incubation. the Ebola virus has already entered the cytoplasm at approximately 2 h36. we speculated that intercellular changes within 2 h after SERM treatment should mediate the cholesterol accumulation and the inhibition of Ebola entry. both U18666a and SERMs significantly decreased the sphingosine of HepG2 and Hela cell lines after 1 h treatment. the results showed that both SERMs and U18666a significantly up-regulated the calcium release from the GPN-sensitive endolysosomal calcium store. fluo8-AM calcium indicator detected endolysosomal calcium release of HepG2 at 1 s, 60 s, 90 s, 330 s, 390 s, and 420 s after incubation of 10 M tamoxifen, clomiphene or U18666a for 1 h. effects of endolysosomal calcium specific chelator on Ebola/WSN/VSV pseudovirions entry. NH4Cl serves as a negative control. we choose the pNL4-3-Luc-RE based Ebola pseudovirion to study the Ebola entry, and the Ebola VLP-mcherry to study the Ebola internalization. we treated the hepatocellular carcinoma cell line HepG2 with two SERMs (tamoxifen and clomiphene) and infected them with the Ebola pseudovirion. both SERMs selectively inhibited the Ebola entry more than with TPC2 (green, marked with EGFP) and LAMP1 (blue, marked with BFP) from 10 M tamoxifen or 10 M clomiphene treated HepG2. significant differences versus control group are presented by asterisks. to test this possibility, we expressed and purified the domains A and C of NPC134,35. we carried out microScale Thermophoresis (MST) and Isothermal Titration Calorimetry (ITC) to detect interactions between tamoxifen, clomiphene, or U18666a and the NPC1 domains A and C. dose-response inhibition of Ebola entry for tamoxifen, clomiphene and U18666a. data are expressed as the means SEM (n = 3) significant differences versus control group are presented by asterisks. cells were treated with 10 M tamoxifen, clomiphene or U18666a for 1 h. lipids were extracted and the levels of Sph were analysed. HepG2 cells were pre-treated with 10 M tamoxifen, clomiphene or U18666a for 1 h. chelation of endolysosomal calcium specifically inhibited the entry of Ebola. arrows indicate examples of colocalization. significant differences versus control group are presented by asterisks (*), **P 0.01, ns means no significant. the heavily glycosylated mucin-like domain and glycan cap of GP1 is removed by the low pH-dependent Cathepsins L and B. the GP1 receptor binding domain interact with the NPC1 domain C within the endolysosome44,45. this interaction between GP1 and NPC1 domain C and low pH conditions are essential for subsequent membrane fusion15,34,46. the authors emphasized that the inhibition of Ebola requires 100-fold higher concentrations of U18666A. they excluded the possibility that U18666a interacts with the SSD of NPC1 to inhibit the Ebola entry49. a structural analysis revealed that 45 of the 80 drugs are CADs. CADs can induce the detachment of ASM protein from the inner endolysosome membranes leading to inactivation. sphingosine treatment could induce the deregulation of endolysosomal calcium. a subsequent study showed that TPC1 and TPC2 mediate the endolysosomal calcium response to sphingosine54. chelating luminal endocytic calcium with high-affinity Rhod-dextran also blocks Ebola infection, but not internalization of Ebola VLP to TPC2+ lysosome. this study revealed the mechanism of Ebola inhibition by toremifene, however, binding and destabilize CADs with anti-Ebola activities inhibit Ebola and/or MARV infection at similar kinetics. binding with GP plays a major role in Ebola inhibition by toremifene, tamoxifen, clomiphene, raloxifene or U18666a (even other CADs with anti-Ebola activities) CADs are protonated and trapped inside the acidic endolysosome. due to their structural properties, these concentrated CADs induce the detachment of the ASM protein from membranes. without sufficient sphingosine, the endolysosomal calcium outflow mediated by TPC1 and TPC2 are blocked, leading the endolysosomal calcium accumulation. without sufficient sphingosine, the endolysosome calcium outflow mediated by TPC1 and TPC2 are blocked. without the calcium flux, there is no conformational change of the Ebola fusion peptide. thus, there is neither membrane fusion nor Ebola infection. the cells were cultured at 37 \u00b0C in a humidified atmosphere of 5% CO2. the cDNA encoding NPC1 domain C was cloned into pET21a vector. we deleted the mucin (313\u2013463aa) of Ebola GP. coli strain BL21 (DE3) was refolded in vitro using the method previously described58. the refolded NPC1-C was then concentrated and purified by gel filtration on a HiLoad 16/60 Superdex 75 PG column. thermophoresis measured at RT with 20% LED power and 20%/40% MST IR-laser power. data from at least three independently performed experiments were analyzed. each experiment was duplicated three times. 5 104 HepG2 cells were plated in each well of a 96-well dish. cells were then pretreated for 30 min with the indicated concentration of inhibitor or with DMSO vehicle in medium without FBS. cells were then infected with 50 L of Ebola pseudovirion for 48 h. cells were washed twice with ice-cold PBS, incubated in 50 mg/mL filipin for 1 h, and washed 3 times with PBS. the coverslips were mounted and imaged on a Zeiss Axio Observer fluorescence microscope. HepG2 cells were pre-incubated with 10 M tamoxifen, clomiphene or U18666a for 1 h. loaded with 5 M membrane-permeable calcium indicators Fluo8-AM (Abcam, US) for 5 mins at room temperature, then placed into calcium-free buffer for confocal live imaging. D-erythro-sphingosine (Sph) and C17-d-erythro-sphingosine (C17-Sph) were purchased from Avanti Polar Lipids (Alabastar, US) high-affinity Rhod-dextran was used as solvent for tamoxifen and clomiphene citrate. DMSO (Sigma, US) was used as solvent for tamoxifen and clomiphene cit expression vectors were constructed by inserting TPC2 and LAMP1 to pEGFP-N1 and pBFP-N1 vectors. expression and purifications of the A and C domains of NPC1 The NPC1 domains A and C were constructed. Microscale Thermophoresis Affinity measurements using MST were carried out with a Monolith NT.115 instrument (NanoTemper Technologies, Germany) each experiment was duplicated three times. the plasmids were transfected at a ratio of 1:1 and 1:1:1 respectively. VSV and WSN pseudovirions were generated in an identical fashion. a second harvest was conducted at 48 hpt. 50,000 cells were plated on glass coverslips in a 24-well plate. cells were washed twice with PBS, incubated in 50 mg/mL filipin for 1 h. lysed for the luciferase assay according to manufacturer\u2019s instructions. 106 cells were harvested by scraping cells with ice-cold PBS. cell pellets were stored at 80 \u00b0C until use. 25 L of HepG2 cell suspension, 10 L of internal standards and 65 L of methanol were added into a 1.5 mL eppendorf tube. the GPN induced calcium release was quantified with Image J software version 1.42. data for all groups were first tested for normality with the Shapiro-Wilk test."}